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et al., 1997; Lee et al., 1999). In addition, FGF-2 exerts neurotrophic 
and neurite outgrowth activities in culture (Moftah, 2007). However, 
several studies suggest that the regeneration processes of the spinal 
cord occurring after body transection and tail amputation are dif-
ferent (Chernoff et al., 2003).
During body spinal cord regeneration, a decreasing rostrocaudal 
gradient in FGF-2 mRNA expression along the brain stem-spinal 
cord axis was observed by Moftah et al. (2008) in intact Pleurodeles. 
We demonstrated a long-lasting up-regulation of FGF-2 mRNA 
expression in response to spinal transection at the mid trunk level, 
both in brainstem and in the spinal cord below injury. Moreover, 
we showed that FGF-2 was up-regulated in neuroglial, presumably 
undifferentiated, cells.
Astrocytes, also a source of FGF-2, become reactive following 
both central and peripheral nervous system injury (Colburn et al., 
1999; Clarke et al., 2001). These activated astrocytes undergo hyper-
trophy and show up-regulated expression of GFAP (Eng, 1985; Web, 
2008), which is thus used as a key indicator of astrocyte activation 
(Reilly et al., 1997). Furthermore, following a physical insult to 
brain or spinal cord, reactive astrocytes in the vicinity of the dam-
age site show increased FGF-2 immunoreactivity (Gomez-Pinilla 
et al., 1992; Clarke et al., 2001; Smith et al., 2001). However, it has 
also been suggested that following injury the observed increase 
in FGF-2 would induce astrocyte proliferation and contribute to 
astrologists, which has a negative effect on regeneration (Gomez-
Pinilla et al., 1995, 1997; Reilly and Kumari, 1996).
IntroductIon
Spinal cord and brain injuries in humans usually result in crippling 
conditions because of the limited ability of repair in the mammalian 
central nervous system (CNS). In contrast, lower vertebrates as fish 
and Urodele amphibians, can regenerate large areas of their spinal 
cord as adults (Clarke and Ferretti, 1998). The regenerative capacity 
of the CNS in Urodele amphibians is dramatically illustrated follow-
ing complete amputation of the tail. Among the factors suggested to 
play a significant role in spinal cord regeneration is fibroblast growth 
factor-2 (FGF-2), a member of a large family of small peptide growth 
factors with multiple biological activities (Szebenyi and Fallon, 1999). 
The initial event of spinal cord regeneration is the induction of 
migratory behavior in the cells that line the central canal rostral to 
the plane of amputation (Edgar and Singer, 1972; Nordlander and 
Singer, 1978; Arsanto et al., 1992; O’Hara et al., 1992), the ependymal 
cells. These cells retain the structure of radial glial cells throughout life 
(Holder et al., 1990). The evidence that exogenous FGF-2 increases 
proliferation in the ependymal tube in vivo, has suggested that FGF-2 
plays a role in proliferation of neural progenitors in the regenerating 
spinal cord (Zhang et al., 2000). Moreover, it has been shown to play 
a role in maintaining neural progenitor proliferation and keeping 
them undifferentiated in vitro, in controlling neural differentiation 
(Mason, 1996; Pittack et al., 1997; Qian et al., 1997; Alvarez et al., 
1998; Maric et al., 2003), in maintaining immature proliferative 
populations in neurogenic niches in vivo (Zheng et al., 2004) and 
in neuroprotection following injury of the nervous system (Huber 
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Glial fibrillary acidic protein is involved in many cellular func-
tioning processes. Although its function is not fully understood, 
GFAP protein is probably involved in controlling the shape and 
movement of astrocytes. The protein probably also plays a signifi-
cant role in the interactions of astrocytes with other cells, which are 
required for the formation and maintenance of the insulating layer 
(myelin) that covers nerve cells (Web, 2008). Using GFAP knockout 
mice, it has been shown that there is a degeneration of multiple 
astrocyte functions; the myelination becomes abnormal and white 
matter structure deteriorates (Goss et al., 1991). Therefore, GFAP 
is believed to be involved in the long-term upkeep of normal CNS 
myelination.
In order to understand FGF-2 expression dynamics during 
Pleurodeles CNS spontaneous regeneration in vivo, we studied its 
spatio-temporal localization in astrocyte populations using GFAP 
as a marker (Reeves et al., 1989) following spinal cord complete 
transection at the mid-trunk region.
MaterIals and Methods
ManIpulatIon
Animals obtained from Blades Biological ltd (Kent, UK) were kept 
in aquaria at 19°C in circulating filtered tap water and fed twice a 
week with Chironomes larvae. Water was completely renewed twice 
a week. Surgical procedures, handling, and housing of the animals 
were in accordance with protocols approved by the INSERM Ethics 
Committee and conformed to NIH guidelines.
For spinal cord lesion, individuals (n = 7) were transferred to 
an anesthetic medium of MS 222 solution (Sigma, Saint Quentin 
Fallavier, France). Spinal cord was exposed from the dorsal midline 
at the 0.70 SVL level by removing a small dorsal part of the 12th 
vertebra. The dura was cut open and the spinal cord was completely 
transected between spinal segments number 12 and 13 with a pair 
of microdissecting scissors. The completeness of transection was 
confirmed by retraction (about 1 mm) and visual inspection of the 
two spinal cord stumps. Once transection was verified, the wound 
was sutured and spinal-transected animals were kept in individual 
empty tanks, the bottom of which was covered with fresh wet paper. 
When wound healing was complete (8–10 post-operative days), 
spinal-transected animals were transferred back to their aquaria to 
recover. The bladder was pressed manually two to three times each 
week for the first month. Animals did not seem to be in distress, as 
judged from the absence of mucus secretion or aggressive behav-
ior. In sham-operated animals (n = 4), spinal cords were exposed 
by laminectomy but not transected and then treated exactly like 
spinal-transected ones.
IMMunohIstocheMIstry
Sham-operated and spinal-transected animals were anesthetized as 
previously described and perfusion-fixed via the ascending aorta 
with 10 ml Urodele Ringer’s solution (in mM: NaCl, 130; KCl, 2.1; 
CaCl
2
, 2.6; MgCl
2
, 0.2; HEPES, 4; d-glucose, 5; NaHCO
3
, 1; pH 7.4 
at 4°C) as previously tested (Chevallier et al., 2004) followed by 
10 ml of an ice-cold fixative containing 4% paraformaldehyde and 
0.2% picric acid in 0.1 M phosphate buffer (PB, pH 7.4) (Pease, 
1962; Zamboni and De Martino, 1967). The dorsal half of animals 
was cut off, discarding the whole viscera and tail. Skin and muscles 
were removed to expose the vertebral column in a cold oxygenated 
Urodele Ringer’s solution. Brainstem and spinal cord were exposed 
from the dorsal midline by craniectomy and laminectomy, respec-
tively. The dura was cut open and brainstem (BS) and body spinal 
cord (SC) were completely taken out with a pair of microdissecting 
scissors. Spinal cord was then divided into three segments namely 
SC1, SC2, and SC3 corresponding respectively to two pre-lesional 
and one sub-lesional portion of trunk spinal cord.
Brainstem and the three spinal cord regions were then immersed 
in the same fixative for 1 h, and rinsed for at least 24 h in 0.1 M 
PB (pH 7.4) containing 15% sucrose and 0.02% sodium azide 
(Sigma). They were immediately but separately frozen in embed-
ding medium (Tissue-Tek, Sakura, Cergy-Pontoise, France) by 
immersion in −50°C isopentane (Merck, Darmstadt, Germany).
Spinal cord and brainstem sections (250 section/region/animal/
experiment) were cut at 14 μm thickness using a cryostat (Microm, 
Heidelberg, Germany) and thaw-mounted onto Super-Frost Gold 
slides (CML, Nemours, France). Sections were air-dried, rinsed with 
Tris buffer saline (TBS) (0.1 M Tris–HCl, 0.15 M NaCl, pH 7.5) 
and double labeled with rabbit anti-FGF-2 (Chemicon, Temecula, 
CA, USA) and mouse anti-GFAP (Dako SA, Trappes, France) as 
follows.
Tissue sections were rinsed for 10 min using TBS containing 
0.05% Tween 20 (TNT) followed by a 30 min incubation with 1% 
(w/v) BSA (Sigma) in TNT (TNT/BSA) for blocking. Sections were 
incubated overnight at 4°C with rabbit anti-FGF-2 primary antibody 
(1:1000 in TNT/BSA) and mouse anti-GFAP (1:500 in TNT/BSA). 
Sections were rinsed with TBS three times 10 min each. FGF-2 and 
GFAP were visualized using an anti-rabbit Alexa Fluor 488 (1:500) 
and an anti-mouse Alexa Fluor 568 (1:500) in dark for 1 h at RT. 
Two rinses with TBS 10 min each were applied followed by bis-
benzamide (1:6000) for one minute to visualize nuclei. Sections were 
then rinsed in Tris–HCl 0.05 M pH 7.4 and finally mounted with 
Dako-antifading mounting medium on cover slips and viewed.
IMagIng
Sections were examined under epi-fluorescence microscope using 
a Zeiss Axiophot 2 microscope (Zeiss, Jena, Germany). Triple 
immunostainings were analyzed with a Leica DMR PCS SP2 AOBS 
confocal microscope (Leica, Heidelberg, Germany) using a ×63 oil 
immersion lens. In all cases, scans were carried out sequentially 
with the 488, 568, and 647 nm lines of the laser. Only single opti-
cal sections were used for illustrations. Digital images were opti-
mized for image resolution (300 dpi final). Brightness, contrast, 
quantification analyses and figures montages were compiled using 
Adobe Photoshop 7.0 ME (Adobe System, San Jose, CA, USA). 
Colocalization quantification was performed using ImageJ (Wayne 
Rasband, NIH, USA).
data analyses
Comparisons between groups were made on sections treated 
together on the same slides under identical conditions. Non-
adjacent sections from SC1-3 and BS were randomly chosen 
after immunohistochemistry procedure. Photomicrographs were 
taken for at least 500 fields (700 μm2 each). Statistical analysis was 
performed using ANOVA and Student’s two-tailed t-test (Flower 
and Cohen, 1997). Values were expressed as percentage of sham 
conditions ± SEM.
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suggests that the neuroglial cells lining the fourth ventricle are a 
major source of FGF-2 starting 1 week after spinal cord lesion. 
We used sham-operated animals as an immunoreactivity thresh-
old (100%) and variations in intensity were proportional to 
shams level.
By the second week, amounts of FGF-2 immunoreactivity 
increased compared to the first week (205.0 ± 12.7%), while 
the amount of GFAP has dramatically decreased (51.3 ± 10%) 
(Figure 1C, Tables 1 and 2). FGF-2 was found in large amounts 
away from the fourth ventricle in cells flanking the ventricle-
lining cells, while few immunoreactivity of GFAP was noticed 
in the same area.
By week 6, while the animal started to recover its locomotor func-
tion, FGF-2 and GFAP were highly increased. They were both found 
in large quantities in cells lining the fourth ventricle (223.8 ± 0.5 
and 123.9 ± 1.1% respectively, Figure 1C, Tables 1 and 2). However, 
very few farther cells showed immunoreactivity.
results
We investigated FGF-2 and GFAP immunoreactivity in order to 
characterize the cellular localization of these proteins in the spinal 
cord after lesion. Monoclonal and polyclonal antibodies were used 
against the active forms of FGF-2 and GFAP. Computer-assisted 
image analysis was used to quantify their immunoreactivity com-
paring treated animals with sham-operated ones.
Double-staining immunohistochemistry using a mouse anti-
GFAP and a rabbit anti-FGF-2 antibody showed the following:
In BraIn steM regIon
By the first week after spinal cord injury, large quantities of FGF-2 
were prominent in cells lining the fourth ventricle (195.3 ± 0.3%) 
(Figures 1A–C; Table 1). The intense amount of FGF-2 decreased 
gradually in cells flanking the neuroglial cells lining the fourth 
ventricle. GFAP immunoreactivity was also found in large amounts 
in the fourth ventricle lining cells and less farther from the lumen 
(105.9 ± 0.3%) (Figures 1A–C, Table 2). The colocalization of 
FGF-2 and GFAP in the same cells (shown in orange, Figures 1A,B) 
Figure 1 | Double labeling of FgF-2 and gFAP in brain stem after 1 week 
of lesion. (A) Sham operated (B) Lesioned cases. Intense FGF-2 and GFAP 
immunoreactivity is obvious in cells lining the fourth ventricle and cells 
surrounding them compared to sham-operated animals. The blue color in 
upper panel is a nuclear marker and orange color in lower panel (arrow) shows 
the colocalization between FGF-2 and GFAP showing the presence of FGF-2 in 
glial cells ×63. (C) Percentages of labeling intensity of FGF-2 and GFAP 
immunoreactivity compared to sham-operated cases in Brain Stem. The graph 
shows significant increase in FGF-2 localization, which was time-dependent 
within 1, 2, and 6 weeks after spinal cord lesion. GFAP slightly increased 
in week 6.
Table 1 | Percentage of labeling intensity of FgF-2 immunoreactivity in 
lesioned animals (n = 7) compared to sham-operated animals (n = 4). 
Counts are mean ± SEM.
region Weeks % of labeling intensity
Brain stem 1 195.3 ± 0.3
 2 205.0 ± 12.7
 6 223.8 ± 0.5
Anterior 1 258.5 ± 6.0
 2 260.5 ± 3.3
 6 145.4 ± 1.1
Middle 1 130.5 ± 32.9
 2 195.0 ± 21.3
 6 212.5 ± 0.7
Posterior 1 191.9 ± 26.7
 2 72.4 ± 11.2
 6 245.9 ± 1.7
Table 2 | Percentage of labeling intensity of gFAP immunoreactivity in 
lesioned animals (n = 7) compared to sham-operated animals (n = 4). 
Counts are mean ± SEM.
region Weeks % of labeling intensity
Brain stem 1 105.9 ± 0.3
 2 51.3 ± 10.0
 6 123.9 ± 1.1 
Anterior 1 1068.9 ± 2.4
 2 1071.7 ± 3.5
 6 1046.3 ± 29.9
Middle 1 114.9 ± 3.6
 2 101.4 ± 2.6
 6 126.1 ± 0.5
Posterior 1 77.8 ± 11.9
 2 106.3 ± 0.0
 6 106.2 ± 0.3
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By the sixth week, quantity of immunoreactive FGF-2 and 
GFAP were slightly decreased. A significant decline in FGF-2 ratio 
(145.4 ± 1.1%) was noticed, although still higher than sham-op-
erated animals. FGF-2 was obvious in the white matter but none 
in the gray matter. In addition, GFAP was also decreased but not 
to the extent of FGF-2, where its ratio declined to 1046.3 ± 29.9% 
(Figure 2C, Tables 1 and 2).
In the MIddle regIon (sc2)
In sham-operated animals, FGF-2 immunoreactivity was extremely 
light, sparse and occasionally present in the white matter. On the other 
hand, GFAP was found in larger amounts than FGF-2 and uniformly 
distributed in the white matter. One week after lesion, FGF-2 was seen 
in the white matter but its labeling intensity was not significantly 
changed compared to shams (130.5 ± 32.9%). GFAP, however, slightly 
increased after lesion (114.9 ± 3.6%) (Figure 3C, Tables 1 and 2).
By the second and sixth week, massive amounts of FGF-2 
(195.0 ± 21.3 and 212.5 ± 0.7% respectively) and less GFAP 
(101.4 ± 2.6 and 126.1 ± 0.5% respectively) were homogene-
In the anterIor regIon (sc1)
By the first week, immunoreactivity of FGF-2 and GFAP was at 
its maximum. They were both obvious in large quantities in the 
white matter and their labeling was significantly increased com-
pared to sham-operated animals (258.5 ± 6 and 1068.9 ± 2.4% 
respectively: Tables 1 and 2). However, they were very rare in gray 
matter (Figures 2A–C), mainly concentrated in ependymal cells 
lining the central canal. Colocalization between FGF-2 and GFAP 
labeling suggests that glial cells within the white matter are the 
main source of FGF-2 in the anterior part of lesioned spinal cord, 
1 week post-operation.
By the second week, FGF-2 and GFAP were found in the gray 
matter. FGF-2 was more abundant in ependymal cells. Labeling 
levels were almost constant compared to sham-operated animals 
(260.5 ± 3.3% for FGF-2 and 1071.7 ± 3.5 for GFAP: Figure 2C, 
Tables 1 and 2).
Figure 2 | Double labeling of FgF-2 and gFAP in anterior region of 
injured spinal cord (SC1) after 1 week of lesion. (A) Sham operated 
(B) lesioned animals. Intense accumulation of FGF-2 immunoreactivity is 
prominent in white matter. GFAP increased significantly in the white matter, as 
well, as compared to sham-operated animals. Mild amounts of FGF-2 and 
GFAP were found in ependymal cells surrounding the central canal (cc). The 
blue color is a nuclear marker while the orange color in lower panel (arrows) 
shows the colocalization between FGF-2 and GFAP (very faint in ependymal 
cells) ×63. (C) Percentages of labeling intensity of FGF-2 and GFAP 
immunoreactivity compared to sham-operated cases in the anterior region of 
the spinal cord (SC1). The graph shows significant increase in FGF-2 and GFAP 
localization.
Figure 3 | Double labeling of FgF-2 and gFAP in the middle region of 
spinal cord (SC2) after 6 weeks of lesion. (A) Sham operated cases ×10 and 
(B) lesioned cases ×63. FGF-2 and GFAP immunoreactivity were intense in 
white matter compared to sham-operated cases. Small amounts of FGF-2 and 
GFAP were found in ependymal cells surrounding the central canal (cc). The 
blue color is a nuclear marker while the orange color in lower panel (arrows) 
shows a strong colocalization between FGF-2 and GFAP (faint in ependymal 
cells). (C) Percentages of the labeling intensity of FGF-2 and GFAP 
immunoreactivity in SC2 compared to the sham-operated cases. The graph 
shows significant increase of FGF-2 starting week 2 while GFAP localization 
increases as early as the first week.
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The same pattern was noticed in SC2 as to the unchanged colo-
calization labeling intensity of FGF-2 and GFAP through time 
although the overall FGF-2 labeling intensity in GFAP-positive cells 
(Figure 5C, left) was significantly less (p < 0.001) than in sham-
operated animals. As to GFAP-negative cells, FGF-2 was found to 
decrease significantly in intensity (p < 0.001) by 6 weeks post-op 
(Figure 5C, right).
We finally assessed FGF-2 labeling in SC3 (Figure 5D). This 
portion of the CNS followed exactly the same pattern as BS 
(Figure 5A) either in GFAP-positive (Figures 5A,D, left) or -nega-
tive (Figures 5A,D, right) cells. However, colocalization was much 
more pronounced in SC3 where it needs to fill the gap after com-
plete spinal cord transection. Although the increasing pattern by 
1–2 weeks post-op in FGF-2-GFAP colocalization was obvious 
in both extremes of the system, FGF-2 intensity reached a level 
25% more colocalization in SC3 than in BS (Table 3). Similarly, 
6 weeks post-op, colocalization was 34% more in SC3 than in BS. 
ously distributed throughout the white matter, while light 
 immunoreactivity was observed in the gray matter (Figures 3A–C, 
Tables 1 and 2). Although the increase of FGF-2 was gradual 
 starting to be significant on week 2, that of GFAP was fluc-
tuating starting as early as the first week and having the 
least  immunoreactivity 2 weeks post-op. Colocalization between 
FGF-2 and GFAP was mainly prominent in white matter and 
very scarce in the neuroglial cells surrounding the central canal 
(Figure 3B: arrows).
In the posterIor regIon (sc3)
A similar pattern was noticed in this part of the spinal cord com-
pared to the previous one. Being the two stumps of the lesion site, it 
has been noted that they almost behave alike when transection was 
made in the mid-trunk region. By the first week, FGF-2 significantly 
increased (191.9 ± 26.7%) compared to sham-operated animals 
(Figure 4C, Tables 1 and 2). However, GFAP immunoreactivity 
dramatically decreased below the shams threshold (77.8 ± 11.9%) 
and was mainly obvious in the white matter where more accumula-
tion of immunoreactive cells were found around the ventral fissure. 
None was seen in the gray matter.
By the second week, GFAP has significantly increased in both gray 
and white matter compared to shams (106.3 ± 0.0%), while FGF-2 
immunoreactivity dropped below shams threshold (72.4 ± 11.2%: 
Figure 4C, Tables 1 and 2), where it was distributed in both gray 
and white matter.
By the sixth week, FGF-2 immunoreactivity had significantly 
increased (245.9 ± 1.7%), while GFAP remained almost con-
stant compared to the previous week (106.2 ± 0.3%, Tables 1 
and 2). The large accumulation was homogeneously distributed 
all over the spinal cord section (Figures 4A–C). A strong wide-
spread colocalization was prominent between FGF-2 and GFAP 
immunoreactivity.
FgF-2 laBelIng IntensIty In gFap-posItIve and  
gFap-negatIve cells
In all regions, there was an obvious FGF-2 expression in GFAP-
positive and -negative cells. In order to better understand the activa-
tion process occurring in astrocytes, we measured the colocalization 
between FGF-2 and GFAP after lesion by assessing FGF-2 intensity 
in both types of cells in each region of the CNS. We found that in 
brainstem region, colocalization of both proteins was mainly evi-
dent during the 1st–2nd week after lesion (68.02 ± 1.6) compared to 
sham-operated animals (13.5 ± 5.5). This concomitant expression 
was significantly decreased (p < 0.001) in a long-lasting manner 
giving rise to a lesser degree of colocalization although significant 
(p < 0.001) compared to shams (Figure 5A, left). The very high 
FGF-2 labeling intensity seen in GFAP-negative cells (Figure 5A, 
right), 1 week post-op, implies that FGF-2 is not only secreted in 
astrocytes but also in neurones to induce astrocyte activation in 
the beginning of the recovery process.
In SC1, colocalization seen between FGF-2 and GFAP did not 
change through the experiment time although it was significantly 
higher (p < 0.001) in both time-points than sham-operated animals 
(Figure 5B, left). Moreover, in GFAP-negative cells (Figure 5B, 
right), FGF-2 intensity increased through time and almost reached 
the GFAP-positive cells level (p = 0.007).
Figure 4 | Double labeling of FgF-2 and gFAP in posterior region of 
spinal cord (SC3) after 6 weeks of lesion. (A) Sham-operated cases ×40 
(B) lesioned cases ×63. Fluorescence imaging showing intense FGF-2 and 
GFAP immunoreactivity in white matter compared to sham-operated cases. 
The blue color is a nuclear marker while the orange color in lower panel 
(arrows) shows a strong widespread colocalization between FGF-2 and GFAP 
all over the spinal cord section. (C) Percentages of FGF-2 and GFAP 
immunoreactivity labeling intensity compared to sham-operated cases by the 
posterior region of spinal cord below the lesion site. The graph shows 
significant increase in FGF-2 in weeks 1 and 6. Increase of GFAP 
immunoreactivity was also observed but was gradual and time-dependent, 
not or slightly exceeding shams threshold.
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 possibly in glial scar formation (Gomez-Pinilla et al., 1995; Smith 
et al., 2001). It is likely that ependymal cells of the Urodele spinal 
cord are closely related to the radial glial cells of mammalian CNS. 
They have a typical radial morphology and express the astrocytic 
marker GFAP (Holder et al., 1990). Mammalian radial glia have 
been shown to be mitotically active neuronal progenitors (Miyata 
et al., 2001; Noctor et al., 2002). Even in the adult mammal, astro-
cytic cells in the subventricular zone have been identified as adult 
neural stem cells both in vitro and in vivo (Doetsch et al., 1999).
Our studies have demonstrated that spinal cord injury leads to 
increased FGF-2 immunoreactivity in reactive brainstem and spi-
nal cord astrocytes. This increment in FGF-2 was time-dependent 
On the other hand, despite its increase, 1–2 weeks post-op, in GFAP-
negative cells and compared to sham-operated animals (p < 0.001), 
FGF-2 labeling intensity showed an extremely lesser level in SC3 
(Table 4) compared to BS (around 50% less) suggesting that astro-
cyte activation does not have to necessarily occur through its secre-
tion and that they are not the sole source of FGF-2.
dIscussIon
In mammalian systems, an increase in FGF-2 has been reported 
following brain injury and it has been suggested that FGF-2 may 
play a role in the cascade of events underlying CNS wound repair, 
particularly in the recruitment and activation of astrocytes and 
Figure 5 | Fibroblast growth factor-2 labeling intensity in gFAP-positive 
ad gFAP-negative cells compared to sham-operated cases in the four 
examined regions of the CNS. The graph shows an evident colocalization 
between FGF-2 and GFAP in lesioned animals brainstem (A) and spinal cord 
(SC1: B and SC3: D) during the whole experimental period except in SC2 (the 
part of the spinal cord above the lesion site: C). Pattern of distribution of 
FGF-2 secreting cells was somehow similar in BS (A) and SC3 (D) but 
the sublesional part showed a much more significant colocalization. Stars 
are comparisons between columns and their previous ones except 
where noted.
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a slight variation in spatial distribution of FGF-2 immunoreactiv-
ity. It mildly decreased in SC3 (below the lesion site) by the second 
week compared to the first week following complete transection 
in the mid-trunk region.
Giampaoli et al. (2003) has shown that, temporally, FGF-2 is 
transiently expressed at early stages of regeneration and is no longer 
detectable by the medium-bud stage. On the other hand, spatially, 
the density of FGF-2 immunoreactive cells following a contusive 
spinal cord injury in adult rats was found to be the greatest a few 
millimeters rostral to the lesion epicenter (Zai et al., 2005). Our 
findings support these results, where FGF-2 immunoreactivity was 
found in large amounts, at the first week, after spinal cord injury, 
and significantly decreased during the second week in SC3. This 
result reveals that FGF-2 intensity was higher during the most active 
proliferative phase. We provide evidence for FGF-2 distribution in 
regenerating ependymal tube cells. We have shown that ependymal 
cells of sham-operated spinal cord did not show FGF-2. However, 
the growth factor immunoreactivity was seen in cells forming the 
ependymal tube by 1 week after lesion. Our studies demonstrated 
that FGF-2 is localized all along the neural axis, starting by cells 
lining the 4th ventricle in brain stem regions and gradually decreas-
ing with the onset of differentiation in the ependymal cells of the 
regenerating cord. Colocalization of FGF-2 and GFAP was obvious 
in all these cells. This shows that FGF-2 is up-regulated in vivo fol-
lowing injury at the mid trunk region in cells having the potential 
to regenerate the spinal cord, neuroglial cells. Previous studies sug-
gested that FGF-2 is implicated in functional recovery following 
a physical insult to the brain or a complete transection of spinal 
cord (Clarke et al., 2001; Smith et al., 2001, Moftah et al., 2008). The 
suggested expression of FGF-2 in reactive astrocytes and ependy-
mal cells is consistent with numerous in vitro studies showing a 
key role for this growth factor in supporting proliferation of both 
embryonic and adult neural progenitors, in vitro (Shihabuddin 
et al., 1997; Moftah, 2007).
The observation of FGF-2 colocalization with GFAP after spinal 
cord injury supports the idea that FGF-2 may stimulate astrocytic 
activation in the brain as predicted by previous studies in vitro 
(Morrison and De Villis, 1981). In addition, Gomez-Pinilla et al. 
(1995) demonstrated that FGF-2 induces the expression of its 
own mRNA, supporting the possibility that the action of FGF-2 
in astrocyte proliferation may be via regulation of its own synthesis 
(Flott-Rahmel et al., 1992). A major target for FGF-2 is astrocytes, 
critical for the maintenance of neural homeostasis and for neuronal 
regeneration after brain damage (Ransom and Kettenmann, 1995). 
Because astrocytes synthesize FGF-2 (Gomez-Pinilla et al., 1994) 
and express FGF receptors (FGFRs) -2 and -3 (Reuss et al., 2000), 
FGF-2 is a major candidate for the autocrine and/or paracrine 
regulation of astroglial cell differentiation, functions, and transition 
to a “reactive” phenotype.
Following a physical insult to the brain, astrocytes show 
increased FGF-2 immunoreactivity, which is the result of 
increased FGF-2 mRNA synthesis (Smith et al., 2001). Similarly, 
an increase in FGF-2 mRNA in the spinal cord precedes the 
observed increase in FGF-2 immunoreactivity (Moftah et al., 
2008) suggesting that it might be responsible, at least in part, 
for the increase in astrocyte immunoreactivity marked by GFAP. 
Alternatively, this may be due to FGF-2 release from injured 
Table 4 | Labeling intensity of FgF-2 immunoreactivity in gFAP-negative 
cells in lesioned animals (n = 7) and in sham-operated animals (n = 4). 
Counts are mean ± SEM.
region Operation Labeling intensity
Brain stem Sham 22.48 ± 7.2
 1 W 121.00 ± 5.5
 6 W 37.06 ± 2.4
Anterior Sham 1.35 ± 0.9
 1 W 23.00 ± 2.1
 6 W 36.13 ± 1.3
Middle Sham 33.14 ± 0.1
 1 W 36.32 ± 0.9
 6 W 25.88 ± 2.6
Posterior Sham 39.70 ± 0.8
 1 W 66.36 ± 4.3
 6 W 36.90 ± 1.4
being obvious as early as 1 week following spinal cord injury, except 
in SC2, and becoming more sustained at 2 weeks, except in SC3. 
Significant increase was obvious at 6 weeks along the CNS axis 
although in SC1, this increase was slightly less than the previous 
weeks but still higher than sham-operated animals. These results 
suggest that FGF-2 is having a rostro-caudal temporal pattern play-
ing an enhancing role in axon regeneration to gap the lesion. This is 
consistent with Madiai et al. (2003) where increased FGF-2 immu-
noreactivity was as early as 1 week and increased by the second 
week after lumbar spinal nerve ligation. Moreover, our previous 
studies on FGF-2 mRNA expression revealed its short and long 
term up-regulation in Pleurodeles’ brainstem and distal spinal cord 
stump (SC3), the target for regenerated descending fibers to extend, 
in response to a mid-trunk spinal cord transection (Moftah et al., 
2008). Additionally, the present results support that of Zhang et al. 
(2000), who stated that significant up-regulation of FGF-2 occurred 
in the first week of spinal cord regeneration while its expression 
dramatically decreased in the third week. We are reporting herein 
Table 3 | Labeling intensity of FgF-2 immunoreactivity in gFAP-positive 
cells in lesioned animals (n = 7) and in sham-operated animals (n = 4). 
Counts are mean ± SEM.
region Operation Labeling intensity
Brain stem Sham 13.47 ± 5.4
 1 W 68.02 ± 1.6
 6 W 42.42 ± 2.9
Anterior Sham 10.17 ± 3.5
 1 W 42.95 ± 1.6
 6 W 42.70 ± 1.6
Middle Sham 63.40 ± 4.5
 1 W 43.48 ± 1.3
 6 W 37.11 ± 1.5
Posterior Sham 44.31 ± 1.3
 1 W 95.43 ± 5.8
 6 W 59.20 ± 2.0
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